By John Coster, RPh., Ph.D.
Economic downturns like the current one produce a double-whammy for federal and state Medicaid budgets: enrollment in the program grows as there’s less money to pay for it. That means more potential for provider reimbursement cuts – something NCPA is trying hard to avoid. Pharmacies can simply not withstand any more Medicaid reimbursement cuts, especially in light of last year’s AWP rollback. Here’s a rundown of some related state activity NCPA’s monitoring, along with federal efforts. Continue reading ‘Medicaid News in the States’
Published January 13, 2010
AMP , AWP , Congress , Government Affairs , Health Care Reform , Industry Trends , Medicaid , pharmacist
Tags: average manufacturer price, average wholesale price, Health Care Reform, Medicaid, pharmacist
By Kevin Schweers
On Capitol Hill it’s crunch time for health care reform as negotiations between House and Senate leaders pick up speed. A top priority for community pharmacies is getting an adequate fix to Medicaid’s reimbursement formula for generic drugs. So we held a briefing today to update reporters on where things stand and to demonstrate the strong, bipartisan support there is in Congress for an equitable reimbursement formula. Here’s a quick recap; a recording of the call is available here. Continue reading ‘Getting that Medicaid AMP Fix Right in Health Reform’
By Kevin Schweers
For an insightful and succinct look at the issues facing community pharmacy today, check out the interview our friends at Drug Topics recently did with Jon Copeland and Bruce Semingson, two longtime NCPA allies and staunch supporters of independent community pharmacy. Mr. Copeland and Mr. Semingson are, respectively, CEO and COO of American Associated Pharmacies, an influential buying group cooperative.
Continue reading ‘Community Pharmacy Issues Raised in Drug Topics Profile’